✦ LIBER ✦

Cost Effectiveness of Saxagliptin and Metformin versus Sulfonylurea and Metformin in the Treatment of Type 2 Diabetes Mellitus in Germany

✍ Scribed by Wilma Erhardt, Klas Bergenheim, Isabelle Duprat-Lomon, Dr Phil McEwan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB44 THE COST-EFFECTIVENESS OF SAXAGLIP

✍ W Erhardt; K Bergenheim; R Townsend; J Puelles Fernandez de Troconiz; P McEwan 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 97 KB

PDB27 COST-EFFECTIVENESS ANALYSIS OF MET

✍ J. Elgart; J. Caporale; E.C. Aiello; M. Waschbusch; L. Jotimliansky; J.J. Gaglia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

PDB35 COST-EFFECTIVENESS ANALYSIS OF MET

✍ J Elgart; J Caporale; JJ Gagliardino; EC Aiello; M Waschbusch; L Jotimliansky 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 69 KB

Cost-effectiveness of dapagliflozin (For

✍ Sabale, Ugne; Ekman, Mattias; Granström, Ola; Bergenheim, Klas; McEwan, Phil 📂 Article 📅 2015 🏛 Elsevier 🌐 English ⚖ 975 KB

PDB45 COST-EFFECTIVENESS ANALYSIS OF SAX

✍ de Ramirez; A Arellano; M Brosa; J Franch; D Mauricio; C Alvarez; M Sanchez-Zamo 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB

PDB9 Cost-Effectiveness Analysis of Saxa

✍ E.E. Arinina; M. Rashyd 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB